Victory Square Provides Update on Hydreight and Healthcare Investments Following FDA Advisory Committee Recommendations on Peptide-Related Bulk Drug Substances
· cision pr newswire
AI Briefing
- • Victory Square Technologies provides update on investments following FDA advisory committee recommendations on peptide-related bulk drug substances.
- • Hydreight Technologies reports on progress following FDA advisory committee recommendations on peptide-related bulk drug substances.
- • No specific updates on healthcare investments provided, only Hydreight update.
Source Summary
VANCOUVER, BC, July 29, 2026 /PRNewswire/ -- Victory Square Technologies Inc. ("Victory Square", "VST" or the "Company") (CSE: VST) (OTCQX: VSQTF) (FWB: 6F6) is providing shareholders with an update following today's news release issued by Hydreight Technologies Inc. ("Hydreight")...
Advertisement